Pharma stocks zoom: Laurus Labs, Aurobindo hit new highs in trade
BSE is in focus.
21 Sept 2026 · Business Standard Mkts
The BSE Healthcare index rallied over 1% in Monday's trade. Thus far in the financial year 2026-27, it outperformed the market by soaring 25%, against a near 4% rise in the BSE Sensex.
The analysis
BSE reported movement of 1%, 4% and 25%. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Because the driver here is macro rather than company-specific, the read-through is to index-level positioning rather than to any single name — correlations tend to rise when the whole market faces the same signal.
Why it matters
- With BSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- This is a market-wide development — its reach goes beyond any single stock.
- Sector exposure: Pharma & Healthcare.
- The immediate tone of coverage reads positive.
In this story
Related coverage
Market wrap: ITC, BSE, HCL Tech, Asian Paints top gainers and losers on Nifty and Sensex on Monday
Stock Market Today LIVE: Sensex Rises 500 Points, Nifty 50 Holds 22,700; India VIX Leaps 7%; Trent Rallies 12%
Last line of defence! How 7 Nifty stocks survived the market’s two-month bloodbath
Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in Nifty 2027 index review